4. 邮件：pxiongfei@scu.edu.cn；pxiongfei@gmail.com

5. 个人简历

   2022年至今  尊龙凯时华西第二尊龙凯时，流行病学与人群健康实验室PI

   2019年至2021年 美国范德堡大学医学中心，博士后

   2018年至2019年 澳大利亚乔治全球健康研究院，博士后

   2016年至2018年 华中科技大学，博士后

   2010年至2016年 尊龙凯时，博士

   先后在中、英、澳、美四国的大学或研究机构接受流行病与卫生统计学、公共卫生、营养学相关教育和培训，长期致力于基于大型纵向队列探索心血管代谢性疾病的危险因素、病因机制、不良健康影响。截止2022年底已累计在Lancet Diabetes & Endocrinology、Diabetologia、Mayo Clinic Proceedings、American Journal of Clinical Nutrition、European Journal of Endocrinology、Environment International、The Journals of Gerontology: Series A Medical Sciences、Engineering、Journal of Clinical Endocrinology and Metabolism、American Journal of Epidemiology、Obesity等著名学术期刊上发表50余篇第一作者或通讯作者（含共同）学术文章。实验室已建立流行病学、生物统计学、生物信息学、营养学、微生物组学跨学科研究团队。ResearchGate页面: http://www.researchgate.net/profile/Xiongfei-Pan

6. 代表性论文

1. Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392

2. Zeng Q^#, Li N^#, Pan XF^#, Chen L, Pan A. Clinical management and treatment of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6): 373-92 (^#共同第一作者)

3. Pan XF^#, Yang JJ^#, Shu XO, Moore SC, Palmer ND, Guasch-Ferré M, Herrington DM, Harada S, Eliassen H, Wang TJ, Gerszten RE, Albanes D, Tzoulaki I, Karaman I, Elliott P, Zhu H, Wagenknecht LE, Zheng W, Cai H, Cai Q, Matthews CE, Menni C, Meyer KA, Lipworth LP, Ose J, Fornage M, Ulrich C, Yu D. Associations of circulating choline and its related Metabolites with cardiometabolic biomarkers: an international pooled analysis. Am J Clin Nutr. 2021; 114(3): 893-906 (^#共同第一作者)

4. Pan XF^#, Huang Y^#, Li X^#, Wang Y, Ye Y, Chen H, Marklund M, Wen Y, Liu Y, Zeng H, Qi X, Yang X, Yang CX, Liu G, Gibson RA, Xu S, Yu D, Chen D, Li Y, Mei ZX, Pan A, Wu JHY. Circulating fatty acids and risk of gestational diabetes mellitus: prospective analyses in China. Eur J Endocrinol. 2021; 185(1): 87-97 (^#共同第一作者)

5. Pan XF, Xu J, Meng Q. Integrating social health insurance systems in China. Lancet. 2016; 387 (10025): 1274–75 (correspondence)

6. Pan XF, Li Y, Franco OH, Yuan JM, Pan A, Koh WP. Impact of combined lifestyle factors on all-cause and cause-specific mortality and life expectancy in Chinese: the Singapore Chinese Health Study. J Gerontol A Biol Sci Med Sci. 2020; 75 (11), 2193-2199

7. Pan XF, He MA, Yu CQ, Lv J, Guo Y, Bian Z, Yang L, Chen YP, Wu TC, Chen ZM, Pan A, Li LM. Type 2 diabetes and risk of incident cancer in China: a prospective study among 0.5 million Chinese adults. Am J Epidemiol. 2018;187 (7): 1380-1391

8. Wang Y, Huang Y, Wu P, Ye Y, Sun F, Yang X, Lu Q, Yuan J, Liu Y, Zeng H, Song X, Yan S, Qi X, Yang CX, Lv G, Wu JHY, Liu G, Pan XF*, Chen D, Pan A*. Plasma lipidomics in early pregnancy and risk of gestational diabetes mellitus: a prospective nested case-control study in Chinese women. Am J Clin Nutr 2021;114(5):1763-1773（*共同通讯）

9. Pan XF, Chen ZZ, Wang TJ, Shu X, Cai H, Cai Q, Clish CB, Shi X, Zheng W, Gerszten RE, Shu XO, Yu D. Plasma Metabolomic signatures of obesity and risk of type 2 diabetes. Obesity. 2022; 30(11):2294-2306

10. Pan XF, Yang J, Wen Y, Li N, Chen S, Pan A. Non-communicable diseases during the COVID-19 pandemic and beyond. Engineering. 2021; 7(7): 899–902.